4//SEC Filing
LITALIEN JAMES J 4
Accession 0001209191-18-023744
CIK 0001652923other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:56 PM ET
Size
19.9 KB
Accession
0001209191-18-023744
Insider Transaction Report
Form 4
AveXis, Inc.AVXS
LITALIEN JAMES J
SrVP/Chief Reg&Quality Officer
Transactions
- Sale
Common Stock
2018-04-02$120.11/sh−1,052$126,356→ 4,712 total - Sale
Common Stock
2018-04-02$122.14/sh−757$92,460→ 3,955 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-04-02−5,000→ 141,800 totalExercise: $18.17Exp: 2025-08-11→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2018-04-02$18.17/sh+5,000$90,850→ 8,800 total - Sale
Common Stock
2018-04-02$117.10/sh−1,170$137,007→ 7,630 total - Sale
Common Stock
2018-04-02$118.41/sh−569$67,375→ 7,061 total - Sale
Common Stock
2018-04-02$119.43/sh−1,297$154,901→ 5,764 total - Sale
Common Stock
2018-04-02$123.32/sh−155$19,115→ 3,800 total
Footnotes (8)
- [F1]These sales were effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on September 13, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.90 to $117.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.90 to $118.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.94 to $119.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.94 to $120.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.95 to $122.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.97 to $123.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4.
- [F8]37,950 shares vested and became exercisable on July 20, 2016; the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter until July 20, 2019, subject to the Reporting Person's continuous service with the Issuer on each such date.
Documents
Issuer
AveXis, Inc.
CIK 0001652923
Entity typeother
Related Parties
1- filerCIK 0001182613
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:56 PM ET
- Size
- 19.9 KB